Renal Insufficiency Chronic
Conditions
Interventions
This is an unblinded randomized controlled clinical trial, with 40 volunteers. The proposed intervention protocol will be strength training associated with the blood flow restriction method. The physi
group 2 (10 adults and elderly people of both sexes with stage 3 Chronic Kidney Disease), with low-load strength training
group 3 (10 adults and elderly people of both sexes with stage 3 Chronic Kidney Disease) with high-load strength training
group 4 (10 adults and elderly people of both sexes with stage 3 Chronic Kidney Disease), without any type of strength training. The groups will be matched in terms of gender, activity level, stage 3
in the 2nd cycle (4t
Sponsors
Empresa Brasileira de Serviços Hospitalares - EBSERH
Hospital Universitário Professor Alberto Antunes da Universidade Federal de Alagoas
Eligibility
Age
35 Years to 75 Years
Inclusion criteria
Inclusion criteria: volunteers with stage 3 chronic kidney disease; both sexes; aged between 35 and 75 years; without a diagnosis of Hepatitis C or B; without flu-like syndromes; without coagulation dysfunction or signs of thrombophlebitis; without severe arrhythmia, angina or cerebrovascular or cardiovascular disease; without pulmonary congestion or peripheral edema; ankle-brachial index within normal standards
Exclusion criteria
Exclusion criteria: volunteers who suffer from any hypokinetic or osteoarticular disease or cardiovascular events during the intervention; medical recommendations to leave the study; attendance of less than 85% of the sessions planned for the intervention; personal needs and wishes to withdraw from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We expected to find an improvement in kidney function, as assessed by blood tests, with a decrease in the variable mean creatinine of 0.30 mg/L. Data collected one week before the intervention and one week after the end of the intervention;We expected to find an improvement in kidney function, as assessed by blood tests, with a decrease in the variable mean Cystatin-C of 0.50 mg/L. Data collected one week before the intervention and one week after the end of the intervention;e expected to find an improvement in kidney function, assessed by urine tests, with a decrease in the variable mean of a decrease in microalbuminuria of 50 mg/L. Data collected one week before the intervention and one week after the end of the intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that there will be an improvement in the perception of quality of life, as assessed by the Short Form Quality of life 36 questionnaire, with an average increase of 15 points in the dimensions of the instrument. Data collected one week before the intervention and one week after the end of the intervention;It is expected to find an improvement in functional capacity levels, assessed using the physical tests proposed by Rickli & Jones, with an average increase of 3kg/f in strength tests. Data collected one week before the intervention and one week after the end of the intervention;We expect to find an improvement in functional capacity levels, assessed using the physical tests proposed by Rickli & Jones, with an average increase of 4.0 cm in the flexibility tests. Data collected one week before the intervention and one week after the end of the intervention;It is hoped to find an improvement in functional capacity levels, assessed using the physical tests proposed by Rickli & Jones, with an average increase of 100m in the walking test. Data collected one week before the intervention and one week after the end of the intervention | — |
Countries
Brazil
Contacts
Public ContactAntonio Caetano
Universidade Federal de Alagoas
Outcome results
None listed